MiR-145 modulates the radiosensitivity of non-small cell lung cancer cells by suppression of TMOD3
H Li, S Zhao, X Chen, G Feng, Z Chen, S Fan - Carcinogenesis, 2022 - academic.oup.com
Radioresistance is a major problem encountered in the treatment of non-small cell lung
cancer (NSCLC). Aberrant microRNA (miRNA) expression contributes to multiple cancer …
cancer (NSCLC). Aberrant microRNA (miRNA) expression contributes to multiple cancer …
Molecular Targets in Lung Cancer: Study of the Evolution of Biomarkers Associated with Treatment with Tyrosine Kinase Inhibitors—Has NF1 Tumor Suppressor a Key …
BO Alen, LS Estévez-Pérez, MT Hermida-Romero… - Cancers, 2022 - mdpi.com
Simple Summary Resistance to tyrosine kinase inhibitors in patients with EGFR-mutated non-
small cell lung cancer is crucial in the development of the disease. Detecting the …
small cell lung cancer is crucial in the development of the disease. Detecting the …